1. Sickle Cell Disease Core Concepts for the Emergency Physician and Nurse
Epidemiology, Genetics, Pathophysiology
Spring 2013
Paula Tanabe, PhD, RN, FAEN, FAAN
Associate Professor
Duke University, Schools of Nursing and Medicine

2. Objectives
Identify the genotype associated with the most severe form of SCD.
Identify the median lifespan for individuals with SCD.

3. Pre-test Which genotype is associated with the most severe symptoms?SC
SB0
SB+

4. Pre-test 2. What is the median lifespan for most individuals with SCD?

5. Epidemiology of SCD
SCD is a genetic disease affecting 70,000 – 100,000 Americans, primarily of African descent (Hassell, 2010)
Most common genetic disease among blacks
SCD occurs in 1 of every 500 black births
1:1,100 Hispanics (eastern states)
1:32,000 Hispanics (western states)
SCD occurs in many other ethnic groups, including Northern Europeans and those that live in the Middle Eastern Countries
1:12 African-Americans are carriers (trait) for the disorder
While considered a rare disease SCD still affects approximately 100,000 individuals in the United States.
It is a genetic disease, babies are born with it.
SCD is most prevalent in the United States among African Americans, but not exclusively.
Sickle cell trait is very common among African Americans.
Two parents with trait have a 25% change of having a child with sickle cell disease.

6. Comparison of Life Expectancy US Population vs. Sickle Cell Disease
Persons with SCD continue to experience a shortened life expectancy of approximately 30 years when compared to the general population.

7. Changes in Life Expectancy
National Center for Health Statistics (CDC)
Compared with
Largest declines in ages 0-4
Smaller but significant declines up to age 19
Due to prophylactic treatment with penicillin and vaccinations
Transcranial doppler screening identifies children at risk of stroke; placed on chronic transfusion therapy to prevent stroke
No differences in the age group
Increase in death rate ages: 45-54, 55-65, and 65-75
Significant improvement in childhood mortality has occurred since the advent of newborn screening.
All newborns are now screened for SCD.
Babies with SCD are placed on penicillin until age 5 and receive pneumococcal vaccination. This prevents sepsis and death.
Transcranial doppler screening is also performed to identify children at high risk of stroke.
These children are placed on a monthly chronic transfusion program to prevent stroke.

8. What is the pathophysiology?
Sickle cells have many abnormal properties and change shape under conditions of de-oxygenation.
Cells are sticky and begin to form long polymers and obstruct blood flow and oxygen delivery.
All tissues and organ systems require oxygen.
Over the lifespan, organ damage can occur to all organ systems.
During an acute vaso-occlusive crisis, oxygen delivery is compromised and severe pain results.

9. Normal Vs. Sickle Red Cells
Sickle-shaped
Rigid
Live for 20 days or less
Sticky surface, abnormal properties
Normal
Biconcave disc-shaped
Deformable
Life span of 120 days
Sickle cells have many, many abnormal properties.
Persons with sickle cell have chronic anemia.
It is important to know an individual patients’ baseline hemoglobin before determining whether transfusion is needed, and to identify aplastic crisis, a life-threatening condition.

10. Prolonged Sickling of RBC’s
After recurrent episodes of sickling
membrane damage occurs
cells not capable of resuming biconcave shape upon re-oxygenation
Deformed sickle cells adhere to endothelium & macrophages
induces hemolytic process
Over time, blood vessel and organ damage occurs.

11. Hemolysis and Vaso-occlusion
▪ Anemia in SCD is caused by red cell destruction, or hemolysis
▪ The degree of anemia varies widely between patients
▪ Red cell production by the bone marrow increases dramatically, but is unable to keep pace with the destruction
Vaso-occlusion:
Complex process initiated by rigid and abnormally shaped sickled RBC’s
Abnormal adhesion occurs to the endothelium
Activation of WBC’s, RBC’s and the endothelial surface which enhances the VOC process
Results in tissue damage, hypoxia, necrosis and organ dysfunction
The primary pathophysiologic processes of SCD are hemolysis and vaso-occlusion.

12. Acute and Chronic Manifestations
Acute Manifestations:
Bacterial sepsis or meningitis*
Recurrent vaso-occlusive pain (dactylitis, musculo-skeletal or abdominal pain)
Splenic sequestration*
Aplastic crisis*
Acute chest syndrome*
Stroke*
Priapism
Hematuria, including papillary necrosis
Chronic Manifestations:
Anemia
Jaundice
Splenomegaly
Functional asplenia
Cardiomegaly and functional murmurs
Hyposthenuria and enuresis
Proteinemia
Cholelithiasis
Delayed growth and sexual maturation
Restrictive lung disease*
Pulmonary hypertension*
Avascular necrosis
Proliferative retinopathy
Leg ulcers
Transfusional hemosiderosis*
Persons with SCD experience a wide variety of both acute and chronic complications.
The bolded starred complications are causes of mortality.
All of these complications contribute to the severely shortened lifespan.
*Potential cause of mortality

13. Sickle Cell Disease (SCD) Common Genotypes
Approximate % of US Patients
Genotype
Sickle cell anemia (SS, most severe form)
Sickle/Hb C disease (SC, lesser severity, but can still have pain episodes, and life-threatening complications)
Sickle/Beta plus thalassemia (Sβ+ thalassemia, similar to SC)
Sickle/Beta zero thalassemia (Sβ° thalassemia, similar to SS)
65 %
25 %
8 %
2 %
The term sickle cell disease describes a group of complex, chronic disorders, not simply Sickle Cell Anemia (SS)
SS is the most common and severe form of the disease.
SC disease is considered to be a less severe form of the disease. However, patients with SC disease more frequently experience retinopathy and blindness, and avascular necrosis of the hips and shoulders.
In some persons, a sickle gene combines with a gene for beta thalassemia is inherited from the other.
SB0 is the more severe form and similar to SS disease.
SB+ is less severe and more similar to SC disease.
Persons without the disease, but with trait typically do not have symptoms. However, no research has been done to determine if patients with trait have symptoms. It is important that persons with trait receive reproductive counseling.

14. References
Hassell KL. Population estimates of sickle cell disease in the U.S. Am J Prev Med. 2010;38(4S):S512-S521.
Platt et al. Mortality in sickle cell disease, life expectancy and risk factors for early death. NEJM :
Hamideh, D. Trends in Mortality Among Patients with SCD in the United States. Is there any change in the past 10 years? th Annual Sickle Cell Disease Research and Educational Symposium & Annual National SCD Scientific Meeting

15. Post-Test Which genotype is associated with the most severe symptoms?SC
SB0
SB+

16. Post-Test
2. What is the median lifespan for most individuals with SCD?
20’s
30’s
40’s
50’s